• Je něco špatně v tomto záznamu ?

Hemodynamic Correlates and Diagnostic Role of Cardiopulmonary Exercise Testing in Heart Failure With Preserved Ejection Fraction

YNV. Reddy, TP. Olson, M. Obokata, V. Melenovsky, BA. Borlaug,

. 2018 ; 6 (8) : 665-675. [pub] 20180523

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural

Perzistentní odkaz   https://www.medvik.cz/link/bmc19045441

Grantová podpora
R01 HL128526 NHLBI NIH HHS - United States
T32 HL007111 NHLBI NIH HHS - United States
U01 HL125205 NHLBI NIH HHS - United States
U10 HL110262 NHLBI NIH HHS - United States
R01 HL126638 NHLBI NIH HHS - United States

OBJECTIVES: This study sought to define the invasive hemodynamic correlates of peak oxygen consumption (Vo2) in both supine and upright exercise in heart failure with preserved ejection fraction (HFpEF) and evaluate its diagnostic role as a method to discriminate HFpEF from noncardiac etiologies of dyspnea (NCD). BACKGROUND: Peak Vo2 is depressed in patients with HFpEF. The hemodynamic correlates of reduced peak Vo2 and its role in the clinical evaluation of HFpEF are unclear. METHODS: Consecutive patients with dyspnea and normal EF (N = 206) undergoing both noninvasive upright and invasive supine cardiopulmonary exercise testing were examined. Patients with invasively verified HFpEF were compared with those with NCD. RESULTS: Compared with NCD (n = 72), HFpEF patients (n = 134) displayed lower peak Vo2 during upright and supine exercise. Left heart filling pressures during exercise were inversely correlated with peak Vo2 in HFpEF, even after accounting for known determinants of O2 transport according to the Fick principle. Very low upright peak Vo2 (<14 ml/kg/min) discriminated HFpEF from NCD with excellent specificity (91%) but poor sensitivity (50%). Preserved peak Vo2 (>20 ml/kg/min) excluded HFpEF with high sensitivity (90%) but had poor specificity (49%). Intermediate peak Vo2 cutoff points were associated with substantial overlap between cases and NCD. CONCLUSIONS: Elevated cardiac filling pressure during exercise is independently correlated with reduced exercise capacity in HFpEF, irrespective of body position, emphasizing its importance as a novel therapeutic target. Noninvasive cardiopulmonary testing discriminates HFpEF and NCD at high and low values, but additional testing is required for patients with intermediate peak Vo2.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19045441
003      
CZ-PrNML
005      
20200114152820.0
007      
ta
008      
200109s2018 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.jchf.2018.03.003 $2 doi
035    __
$a (PubMed)29803552
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Reddy, Yogesh N V $u Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.
245    10
$a Hemodynamic Correlates and Diagnostic Role of Cardiopulmonary Exercise Testing in Heart Failure With Preserved Ejection Fraction / $c YNV. Reddy, TP. Olson, M. Obokata, V. Melenovsky, BA. Borlaug,
520    9_
$a OBJECTIVES: This study sought to define the invasive hemodynamic correlates of peak oxygen consumption (Vo2) in both supine and upright exercise in heart failure with preserved ejection fraction (HFpEF) and evaluate its diagnostic role as a method to discriminate HFpEF from noncardiac etiologies of dyspnea (NCD). BACKGROUND: Peak Vo2 is depressed in patients with HFpEF. The hemodynamic correlates of reduced peak Vo2 and its role in the clinical evaluation of HFpEF are unclear. METHODS: Consecutive patients with dyspnea and normal EF (N = 206) undergoing both noninvasive upright and invasive supine cardiopulmonary exercise testing were examined. Patients with invasively verified HFpEF were compared with those with NCD. RESULTS: Compared with NCD (n = 72), HFpEF patients (n = 134) displayed lower peak Vo2 during upright and supine exercise. Left heart filling pressures during exercise were inversely correlated with peak Vo2 in HFpEF, even after accounting for known determinants of O2 transport according to the Fick principle. Very low upright peak Vo2 (<14 ml/kg/min) discriminated HFpEF from NCD with excellent specificity (91%) but poor sensitivity (50%). Preserved peak Vo2 (>20 ml/kg/min) excluded HFpEF with high sensitivity (90%) but had poor specificity (49%). Intermediate peak Vo2 cutoff points were associated with substantial overlap between cases and NCD. CONCLUSIONS: Elevated cardiac filling pressure during exercise is independently correlated with reduced exercise capacity in HFpEF, irrespective of body position, emphasizing its importance as a novel therapeutic target. Noninvasive cardiopulmonary testing discriminates HFpEF and NCD at high and low values, but additional testing is required for patients with intermediate peak Vo2.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a srdeční katetrizace $7 D006328
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a dyspnoe $x etiologie $7 D004417
650    _2
$a zátěžový test $x metody $7 D005080
650    _2
$a tolerance zátěže $7 D017079
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a srdeční selhání $x komplikace $x diagnóza $x patofyziologie $7 D006333
650    _2
$a hemodynamika $7 D006439
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    12
$a spotřeba kyslíku $7 D010101
650    _2
$a tlak $7 D011312
650    12
$a tepový objem $7 D013318
650    _2
$a supinační poloha $7 D016683
655    _2
$a časopisecké články $7 D016428
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
700    1_
$a Olson, Thomas P $u Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.
700    1_
$a Obokata, Masaru $u Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.
700    1_
$a Melenovsky, Vojtech $u Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
700    1_
$a Borlaug, Barry A $u Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota. Electronic address: borlaug.barry@mayo.edu.
773    0_
$w MED00184931 $t JACC. Heart failure $x 2213-1787 $g Roč. 6, č. 8 (2018), s. 665-675
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29803552 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200109 $b ABA008
991    __
$a 20200114153152 $b ABA008
999    __
$a ok $b bmc $g 1483710 $s 1084114
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 6 $c 8 $d 665-675 $e 20180523 $i 2213-1787 $m JACC. Heart failure $n JACC Heart Fail $x MED00184931
GRA    __
$a R01 HL128526 $p NHLBI NIH HHS $2 United States
GRA    __
$a T32 HL007111 $p NHLBI NIH HHS $2 United States
GRA    __
$a U01 HL125205 $p NHLBI NIH HHS $2 United States
GRA    __
$a U10 HL110262 $p NHLBI NIH HHS $2 United States
GRA    __
$a R01 HL126638 $p NHLBI NIH HHS $2 United States
LZP    __
$a Pubmed-20200109

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...